Found 11 matching trials
Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma
EARLY_PHASE1MPM patients are not eligible for surgical procedures like decortication or...
Location
University Hospital Zurich, Division of Oncology
Laboratory-Treated T Cells After Second-Line Chemotherapy in Treating Patients With HER2/Neu-Negative Metastatic Breast Cancer
PHASE2RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Location
Barbara Ann Karmanos Cancer Institute
A Digital Approach to Improving Carbohydrate Periodisation Behaviours in Athlete: SMART+ Study
NAThe carbohydrate periodisation framework is a widely accepted nutritional i...
Location
Liverpool John Moores University
TIL Therapy in Non-small-cell Lung Cancer (NSCLC) Patients
PHASE2Aim of the study is to investigate the efficacy and safety of adoptive cell...
Location
Department of Medical Oncology, University Hospital Basel
The Role of Immune Checkpoints in Lung Transplant (ILTRA)
N/AThe goal of this observational study is to learn about rejection in lung tr...
Location
Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico
HHV-6-specific T-cell Reconstitution Among Children and Adolescents After Allogeneic Stem.
N/AHuman herpesvirus 6 (HHV-6) causes only minor symptoms in healthy individua...
Location
Multiple Locations
Sterile Inflammation and Molecular Aberrations in MDS
N/AThe objective of this study is the description of the possible association ...
Location
Medical University of Innsbruck
3rd Generation GD-2 Chimeric Antigen Receptor and iCaspase Suicide Safety Switch, Neuroblastoma, GRAIN
PHASE1Subjects that have relapsed or refractory neuroblastoma are invited to take...
Status
Active Not Recruiting
Location
Houston Methodist Hospital
Safety and Impact of Dasatinib on Viral Persistence and Inflammation in People With HIV Under Antiretroviral Treatment
PHASE2The goal of this clinical trial is to evaluate the safety, tolerability and...
Location
Hospital Universitari Germans Trias i Pujol
Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC
PHASE2This is an open-label, single-arm phase II study of bipolar androgen therap...
Location
Yale Cancer Center